85821-7Influenza virus B Victoria lineage Ag [Presence] in Isolate by Hemagglutination inhibitionActive
Part Descriptions
LP182335-2 Influenza virus B Victoria lineage
Influenza B viruses can be separated into two major lineages, B/Victoria and B/Yamagata. Recent studies have shown that the two major lineages may differ in terms of epidemiology and risk of secondary infection. One study found that patients with confirmed influenza B Victoria lineage infections were significantly younger compared to patients infected with the Yamagata lineage.[PMID:25034374] A separate study found that Victoria-lineage viruses were associated with a significantly higher risk of secondary infection among patients' household contacts who were 15 years old or younger than among those older than 15, but the same did not hold true for Yamagata-lineage viruses.[PMID:26400854] Studies have also shown that genetically distinct lineages like B/Victoria/2/87 can cocirculate in the population and that the reassortment among these strains plays a role in generating the genetic diversity of influenza B viruses. [PMID:16891481]
Source: Regenstrief LOINC
LP6304-2 HAI
The hemagglutination-inhibition assay (HAI) can be used to identify subtypes of hemagglutinin producing viruses, such as Influenza. HAI can also be used to identify the subtype-specificity of antibodies against the virus. Normally, Influenza's hemagglutinin glycoprotein binds to receptors on the surface of red blood cells, causing them to agglutinate. If antibodies specific to the virus are present in the patient sample, they will bind to the virus, which prevents the virus from binding to the red blood cells and therefore prevents agglutination. To determine which subtype of virus is present, a viral isolate is tested against a series of antibodies with known subtype specificities. Whichever antibody inhibits red cell agglutination identifies the viral subtype. Similarly, antibody specificity is identified by testing the patient sample against known virus subtypes. [PMID:24899416]
Source: Regenstrief LOINC, B blood group
Fully-Specified Name
- Component
- Influenza Virus B Victoria lineage Ag
- Property
- PrThr
- Time
- Pt
- System
- Isolate
- Scale
- Ord
- Method
- HAI
Additional Names
- Short Name
- FLUBV Vic Ag Islt Ql HAI
- Display Name
- FLUBV Vic Ag HAI Ql (Isol)
- Consumer Name Alpha
- Influenza B Vic antigen
Example Answer List LL2782-2
Source: Association of Public Health Laboratories
Answer | Code | Score | Answer ID |
---|---|---|---|
Detected | LA11882-0 | ||
Not detected | LA11883-8 | ||
Specimen unsatisfactory for evaluation Copyright http://snomed.info/sct ID:125154007 Specimen unsatisfactory for evaluation (finding) | LA13548-5 |
Basic Attributes
- Class
- MICRO
- Type
- Laboratory
- First Released
- Version 2.61
- Last Updated
- Version 2.61
- Order vs. Observation
- Observation
Member of these Groups
LG32757-3 | Influenza virus |
Language Variants Get Info
- zh-CNChinese (China)
- 流感病毒 B 型 Victoria 谱系 抗原:
存在情况或阈值: 时间点: 分离株: 序数型: 红细胞凝集抑制试验法 - nl-NLDutch (Netherlands)
- Influenzavirus B Victoria lineage Ag:
aanwezigheid: moment: isolaat: ordinaal: hemagglutinatieremming - fr-FRFrench (France)
- Influenza virus B lignée Victoria Ag:
Présence/Seuil: Ponctuel: Isolat: Qualitatif: Hémagglutination indirecte - it-ITItalian (Italy)
- Influenza B, virus , Ag:
PrThr: Pt: Isolato: Ord: HAI - es-MXSpanish (Mexico)
- Virus de la influenza B Victoria linaje Ag:
Presencia o umbral: Punto temporal: Aislado: Ordinal: Inhibición de la hemaglutinación - es-ESSpanish (Spain)
- Linaje Virus Influenza B Victoria Antígeno:
PrThr: Punto temporal: Aislado: Ord: Inhibición de la Hemaglutinación - tr-TRTurkish (Turkey)
- Influenza virus B Victoria lineage Ag:
MevcEşik: Zmlı: İzolat: Srl: HAI
LOINC FHIR® API Example - CodeSystem Request Get Info
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=85821-7
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.
LOINC Copyright
Copyright © 2022 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright